Syneos Health Schedules Second Quarter 2021 Earnings Call for Monday, August 9, 2021
Syneos Health (Nasdaq:SYNH) will release its second quarter 2021 financial results on August 9, 2021, before the earnings call at 8:00 a.m. ET. The earnings call will be accessible via a live webcast on the company's Investor Relations website. Participants can register in advance to join the call by phone, receiving a confirmation email with details on how to connect. A replay of the webcast will be available after 1:00 p.m. on the same day. This event marks an important opportunity for investors to gather insights on the company's performance.
- Scheduled release of second quarter 2021 financial results indicates proactive communication with investors.
- The earnings call provides a platform for discussing company performance and future outlook.
- None.
MORRISVILLE, N.C., July 12, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2021 financial results on Monday, August 9, 2021, prior to its earnings call at 8:00 a.m. ET.
Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on August 9, 2021.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 26,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Investor Relations Contact: Ronnie Speight Senior Vice President, Investor Relations +1 919 745 2745 Investor.Relations@syneoshealth.com | Press/Media Contact: Gary Gatyas Executive Director, External Communications +1 908 763 3428 gary.gatyas@syneoshealth.com |
FAQ
When will Syneos Health release its second quarter 2021 financial results?
What time is the earnings call for Syneos Health's Q2 results?
How can I participate in the Syneos Health Q2 earnings call?